Urology Times spoke with Raoul S. Concepcion, MD, FACS, and Christopher M. Pieczonka, MD, about advances made in the prostate cancer space in 2020.
EP. 1: PSMA in Prostate Cancer
EP. 2: Metastatic Castrate-Resistant Prostate Cancer
EP. 3: PARP Inhibitors and Immunotherapy in Prostate Cancer
FDA clears image-guided navigation platform for focal therapy in prostate cancer
Category III CPT code issued for Enhanced Lithotripsy System
When to report 50320 with 49187 for nephrectomy procedures
Daniel D. Joyce, MD, MS, discusses the economics of trimodal therapy in MIBC